Skip to main content

UDF IV Shareholders Approve Merger with Ready Capital

IRVING, Texas, March 04, 2025 (GLOBE NEWSWIRE) — United Development Funding IV (“UDF IV” or the “Trust”) today announced that, based on the voting results certified by UDF IV’s inspector of elections, First Coast Results, Inc., UDF IV shareholders approved the previously announced merger with Ready Capital Corporation (NYSE: RC) at the UDF IV Special Meeting of Shareholders (the “Special Meeting”) held earlier today. “We thank our shareholders for their support of our merger with Ready Capital,” said Jim Kenney, Managing Trustee and Chief Executive Officer of UDF IV. “This is an exciting milestone for UDF IV and the Trust’s shareholders, and we are pleased to be one step closer to realizing the immediate value and potential long-term upside that we believe this transaction will deliver to our shareholders. The Trust’s Board of...

Continue reading

ButcherJoseph Advises Jim’s Formal Wear on a Sale to Its Employees

ST. LOUIS, March 04, 2025 (GLOBE NEWSWIRE) — Saint Louis, MO, March 2025 – ButcherJoseph & Co. (“ButcherJoseph”) served as financial advisor to Jim’s Formal Wear (“JFW or The Company”) on a sale to its employees through the creation of a new employee stock ownership plan (“ESOP”). The transaction closed on December 30, 2024. Founded in 1964, Jim’s Formal Wear is the largest independent provider of men’s formal wear services in the USA. The Company is headquartered in Trenton, Illinois, and has a network of seven service centers and eight delivery hubs across the country. JFW carries all garment types necessary for formal occasions, including weddings, proms, quinceañeras and other special events. Having successfully navigated to its third generation of family leadership, JFW has expanded over the years into a nationwide distributor...

Continue reading

iLobby Acquires Leading Logistics Management Provider SCLogic and Rebrands as FacilityOS

FacilityOSiLobby has acquired SCLogic and rebranded as FacilityOSTORONTO, March 04, 2025 (GLOBE NEWSWIRE) — iLobby, a global leader in enterprise facility and visitor management solutions, today announced the acquisition of SCLogic, a leading logistics management solution provider, and its rebrand to FacilityOS. For over two decades, SCLogic has been at the forefront of last-yard logistics, delivering innovative solutions that enhance operational efficiency, reliability, and customer satisfaction. By integrating SCLogic’s proven technology and expertise into the FacilityOS platform, the combined company is now positioned as the most comprehensive solution for facility management. “Bringing SCLogic into FacilityOS is a game-changer for the industry,” said Ariel Mashiyev, Chairman and CEO of FacilityOS. “Facility management...

Continue reading

CareSource and ElderServe Health seek affiliation to strengthen long-term care for older adults and adults with disabilities in New York

DAYTON, Ohio and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) — CareSource, a nationally recognized nonprofit managed care organization, today announced that it will seek an affiliation with ElderServe Health, Inc., dba RiverSpring Health Plans (ElderServe Health) through a change-of-control transaction. Subject to state regulatory approval, RiverSpring Living will end its affiliation with ElderServe Health, which will join CareSource’s family of brands. CareSource will strengthen ElderServe Health’s ability to provide high-quality long-term support services, with both organizations bringing their shared members-first approach to more New Yorkers, while RiverSpring Living will focus on residential, supportive and assisted living.  “As demographics continue to shift, the need for long-term services and support will triple by...

Continue reading

Poppulo Strengthens Digital Signage Portfolio with Strategic Acquisition of REACH Media Network

DENVER, March 04, 2025 (GLOBE NEWSWIRE) — Poppulo, a global leader in digital signage and omnichannel employee communications software, today announced its acquisition of REACH Media Network (REACH), a prominent provider of reliable, user-friendly digital signage solutions to mid-market customers. With a combined reach of more than 10,000 digital signage customers worldwide, this strategic acquisition underscores Poppulo’s dedication to delivering high impact digital signage solutions for a broader range of customers and use cases.  With more than 45 years combined experience in the digital signage industry, Poppulo and REACH will drive innovation that helps organizations more effectively use digital signage to improve customer experience, increase revenue, drive brand awareness, improve performance and enhance their workplaces....

Continue reading

XBP Europe Holdings, Inc. Signs Exclusive Non-Binding Letter of Intent to Acquire Exela Technologies BPA, LLC

Merger would expand XBP Europe into a $1 billion revenue business SANTA MONICA, Calif., March 04, 2025 (GLOBE NEWSWIRE) — XBP Europe Holdings, Inc. (“XBP Europe”) (Nasdaq: XBP), a pan-European integrator of bills, payments, and related solutions and services, today announced that it has entered into an exclusive, non-binding letter of intent with Exela Technologies, Inc. to acquire Exela Technologies BPA, LLC (“BPA”), a leading provider of business process automation solutions. The closing of the acquisition will be subject to BPA completing a corporate reorganization which is expected to create a sustainable capital structure with a substantially deleveraged balance sheet. If completed, the acquisition will expand XBP Europe’s revenue to more than $1 billion from $145 million on a pro forma basis for the twelve months ending September...

Continue reading

ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger

All-Stock Transaction with Alumis Maximizes Long-Term Value for ACELYRIN Stockholders LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that, after due consideration in consultation with its independent financial and legal advisors, its Board of Directors determined that the unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital Partners, LP is the controlling shareholder, is not reasonably expected to result in a superior proposal to the planned merger with Alumis Inc. (Nasdaq: ALMS). The ACELYRIN Board of Directors is confident that the all-stock transaction with Alumis maximizes long-term value for ACELYRIN stockholders...

Continue reading

49-Year Business Graphics 3 Sold to New Minuteman Press Franchise Owner Tyler Griffith in Coldwater, MI

Minuteman Press Franchise Coldwater, MINew Minuteman Press Franchise Owner Tyler Griffith (left) has purchased 49-year business Graphics 3 from Mike Iveson (right). Moving forward, the business is operating as Minuteman Press in Coldwater, MI.COLDWATER, Mich., March 04, 2025 (GLOBE NEWSWIRE) — Graphics 3, a second-generation printing business owned by Iveson family for 49 years, has been sold by retiring owner Mike Iveson to new Minuteman Press franchise owner Tyler Griffith. Moving forward, the business will operate as Minuteman Press in Coldwater and remains located at 205 W. Garfield Avenue, Coldwater, MI 49036. On selling the business, Mike shares, “Tyler Griffith has been great to work with, allowing me to decompress from owner to bystander. The transition has been even better than I expected and everything has worked...

Continue reading

ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO, Calif., March 04, 2025 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq: SLRN) and Alumis Inc. (Nasdaq: ALMS) today reaffirmed their commitment to merge in an all-stock transaction, which will create a leading clinical stage biopharma company in immune-mediated diseases. Martin Babler, President, Chief Executive Officer and Chairman of Alumis, said, “Alumis and ACELYRIN together will advance exciting breakthroughs for patients and drive long-term value for stockholders through the creation of a leading clinical stage biopharma company in immune-mediated diseases. The combined company will have a significantly strengthened financial position to support a highly differentiated and diverse pipeline...

Continue reading

Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger

Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet SOUTH SAN FRANCISCO, Calif. and LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS) (“Alumis”) and ACELYRIN, INC. (Nasdaq: SLRN) (“ACELYRIN”) today reaffirmed their commitment to merge in an all-stock transaction, which will create a leading clinical stage biopharma company in immune-mediated diseases. Martin Babler, President, Chief Executive Officer and Chairman of Alumis, said, “Alumis and ACELYRIN together will advance exciting breakthroughs for patients and drive long-term value for stockholders through the creation of a leading clinical stage biopharma company in immune-mediated diseases. The combined company will have a significantly strengthened financial position to support a highly differentiated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.